financetom
Business
financetom
/
Business
/
Market Chatter: Apple's India Sales Surge to Nearly $8 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Apple's India Sales Surge to Nearly $8 Billion
Jul 15, 2024 4:32 AM

07:03 AM EDT, 07/15/2024 (MT Newswires) -- Apple's ( AAPL ) annual sales in India surged to nearly $8 billion, Bloomberg reported on Monday.

Revenue in India rose by about 33% in the year ending March, up from $6 billion the previous year, Bloomberg said, citing a person familiar with the matter.

More than half of this revenue came from sales of Apple's ( AAPL ) high-end iPhones, underpinned by growing demand from an expanding middle class in India just as the iPhone maker seeks to reduce its sales dependence on China.

Apple ( AAPL ) representatives in India didn't respond to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 235.40, Change: +4.86, Percent Change: +2.11

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Xilio Therapeutics' Q3 collaboration revenue rises
Xilio Therapeutics' Q3 collaboration revenue rises
Nov 13, 2025
Overview * Xilio Q3 collaboration revenue rises to $19.1 mln from $2.3 mln year-over-year * Net loss for Q3 widens to $16.3 mln from $14.0 mln year-over-year * Company anticipates cash runway into Q1 2027 Outlook * Xilio plans to submit IND for XTX501 in mid-2026 * Company anticipates cash runway into Q1 2027 * Xilio seeks partner for vilastobart...
Fiera Capital Q3 revenue slightly misses estimates
Fiera Capital Q3 revenue slightly misses estimates
Nov 13, 2025
Overview * Fiera Capital ( FRRPF ) Q3 revenue slightly misses analyst expectations * Adjusted EPS for Q3 meets analyst estimates * Company achieved positive net organic growth in AUM, driven by new relationships Outlook * Company did not provide specific guidance for future quarters or full year Result Drivers * NET ORGANIC GROWTH - Positive net organic growth of...
Palatin fiscal Q1 revenue hits $8.8 mln, net income $4.7 mln
Palatin fiscal Q1 revenue hits $8.8 mln, net income $4.7 mln
Nov 13, 2025
Overview * Palatin fiscal Q1 2026 revenue rises to $8.8 mln, driven by Boehringer Ingelheim agreement * Company reports fiscal Q1 net income of $4.7 mln, reversing a loss from last year * Palatin ( PTN ) completes $18.2 mln public offering, regains NYSE American compliance Outlook * Company plans IND submission and Phase 1 trial for PL7737 in first...
HLS Therapeutics Narrows Q3 Loss as Vascepa Scripts Climb
HLS Therapeutics Narrows Q3 Loss as Vascepa Scripts Climb
Nov 13, 2025
07:43 AM EST, 11/13/2025 (MT Newswires) -- HLS Therapeutics ( HLTRF ) said Thursday that third-quarter net loss narrowed slightly as revenue rose. Net loss improved to US$3.92 million, or $0.12 per share, from a loss of $4.84 million, or $0.15 per share in the prior year period. Revenue decreased 4% to $13.5 million, primarily due to lower Clozaril Canada...
Copyright 2023-2026 - www.financetom.com All Rights Reserved